Samuel So

Surgical oncologist

Liver surgeon

Gastrointestinal (GI) Cancer Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: University of Minnesota (1988) MN

Fellowship: University of Minnesota School of Medicine (1989) MN

Internship: University of Minnesota (1981) MN

Medical Education: University of Hong Kong (1978) China

Fellowship, Univ. of Minnesota, Mpls., MN, Multi-organ Transplantation (1989)

M.B., B.S., Univ. of Hong Kong, Medicine and Surgery (1978)

B.A., summa cum laude, Univ of Minnesota, Mpls., MN, Microbiology (1973)

Honors & Awards

Ronald P Bangasser MD, Immunization Leadership Award, California Immunization Coalition (2014)

Outstanding Individual of the Year, Asian American Women Alliance, Santa Clara, California (2011)

Honor Award for Excellence in Partnering in Global Health, CDC and ATSDR (2010)

Excellence in Partnering Award-Domestic, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (2010)

Outstanding American by Choice Award, US Citizenship and Immigration Services (2010)

Asian American Achievement Award, Organization of Chinese Americans, San Mateo, California (2010)

12th Outstanding World Chinese Award, World Chinese Business Foundation, Hong Kong (2010)

Asian and Pacific Heritage Award for Excellence in Science, California Asian Pacific Islander Joint Legislative Caucus (2009)

Jade Ribbon HBV Outstanding Contribution Award, Second National Workshop of Chinese HBV Carriers' Community, China (2009)

10th Annual Salute to Excellence Award, American Liver Foundation (2008)

Fervent Global Love of Lives Award, Chou-Ta Kuan Cultural and Education Foundation, Taiwan (2008)

34th Annual Award, Chinese Hospital, San Francisco (2007)

Star Award for Community Service, Asian Americans for Community Involvement, San Jose (2007)

Best Doctors in America, Woodard/White Compendium (1998-present)

2005 National Leadership Award, New York University Center for the Study of Asian American Health (2005)

Who's Who in the World, Who's Who in Medicine and Healthcare, Marquis Who's Who LCC (2006-present)

Who’s Who in Science and Technology, Marquis Who’s Who LLC. (2005-present)

Local Hero of the Year Award, KQED Public Radio and Television, San Francisco (2004)

Santiago Ramon y Cajal Award for Outstanding Research in Minority Health, National Minority Health Month, Washington, DC (2003)

Profile of Excellence Award, ABC 7 Television, San Francisco (2004)

Community Hero Award, World Journal Chinese Newspaper (2004)

Stanford University Asian Faculty Award, Stanford University (2003)

Ally Award, Asian and Pacific Islander Wellness Center, San Francisco (2003)

Who’s Who in America, Marquis Who's Who LLC. (2003-present)

Commendation for outreach and increasing awareness about hepatitis B and liver cancer prevention, City and County of San Francisco (2002)

Commendation for Public Service, City of Milpitas, CA (2001)

Distinguished Asian Leadership Award, Asian Business League of San Francisco (2001)

Distinguished Physician Award, Chinese American Physicians Society (2000)

Best Doctors in San Francisco, San Francisco Magazine (1998-present)

Best Doctors in Silicon Valley (Surgery), San Jose Magazine (1998-present)

Administrative Appointments

Special Adviser on Viral Hepatitis, World Health Organization Western Pacific Region, 2011

Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies, 2006

Committee on the Prevention and Control of Viral Hepatitis in the United States, Institute of Medicine of the National Academies, 2008

Roundtable on Health Disparity, Institute of Medicine of the National Academies, 2008

Conflict of Interest Committee, Stanford University School of Medicine, 2008

Appointments and Promotion Committee, Stanford University School of Medicine, 2004

Lui Hac Minh Professor, Stanford University School of Medicine, 2003

Director, Asian Liver Center, Stanford University, 1996

Director, Multidisciplinary Liver Cancer Program, Stanford University Medical Center, 1998

Chair, Cancer Site Team, American Cancer Society, California Division, 2003

Member of the Board, American Cancer Society, California Division, 2002

Member of the National Assembly, American Cancer Society, 2003

Chair, National Task Force on Hepatitis B: Focus on Asian & Pacific Islander Americans, 2004

Consultant, Centers for Disease Control and Prevention, 2005

Co-Chairman and co-founder, Scientific Advisory Board, Studies in Pediatric Liver Transplantation, 1995

Member of the Scientific Advisory Board, Studies in Pediatric Liver Transplantation, 1995

Scientific Studies Committee, American Society of Transplantation, 1997

Informatics and Data Committee, American Society of Transplant Surgeons, 1997

Liver and Intra-Abdominal Organs Committee, American Society of Transplant Physicians, 1995

Pediatric Committee, United Network of Organ Sharing, 1989

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Hospital & Clinics patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma.
Lu, W.-J., Chua, M.-S., & So, S. K. (2014). Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma. Carcinogenesis, 35(4), 915-922.

Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives
Ma, L., Chua, M.-S., Andrisani, O., & So, S. (2014). Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives. WORLD JOURNAL OF GASTROENTEROLOGY, 20(2), 333-345.

Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes.
Zhao, P., Yang, X., Qi, S., Liu, H., Jiang, H., & Cheng, Z. (2013). Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes. BioMed research international, 2013, 759057-?.

Education and counseling of pregnant patients with chronic hepatitis B: perspectives from obstetricians and perinatal nurses in santa clara county, california.
Yang, E. J., Cheung, C. M., So, S. Ks., Chang, E. T., & Chao, S. D. (2013). Education and counseling of pregnant patients with chronic hepatitis B: perspectives from obstetricians and perinatal nurses in santa clara county, california. Asian Pacific journal of cancer prevention , 14(3), 1707-1713.

Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma
Bu, L., Xie, J., Chen, K., Huang, J., Aguilar, Z. P., & Chen, X. (2012). Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma. CONTRAST MEDIA & MOLECULAR IMAGING, 7(4), 363-372.

Low Levels of Knowledge and Preventive Practices Regarding Vertical Hepatitis B Transmission among Perinatal Nurses
Chao, S. D., Cheung, C. M., Yang, E. J., So, S. Ks., & Chang, E. T. (2012). Low Levels of Knowledge and Preventive Practices Regarding Vertical Hepatitis B Transmission among Perinatal Nurses. JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 41(4), 494-505.

A model program for hepatitis B vaccination and education of schoolchildren in rural China
Chen, J. J., Chang, E. T., Chen, Y.- ren, Bailey, M. B., & So, S. Ks. (2012). A model program for hepatitis B vaccination and education of schoolchildren in rural China. INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 57(3), 581-588.

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., & Weissman, I. L. (2012). The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(17), 6662-6667.

Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-beta 2
Sun, C. K., Chua, M.-S., He, J., & So, S. K. (2011). Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-beta 2. NEOPLASIA, 13(8), 735-U111.

San Francisco Hep B Free: A Grassroots Community Coalition to Prevent Hepatitis B and Liver Cancer
Bailey, M. B., Shiau, R., Zola, J., Fernyak, S. E., Fang, T., & Chang, E. T. (2011). San Francisco Hep B Free: A Grassroots Community Coalition to Prevent Hepatitis B and Liver Cancer. JOURNAL OF COMMUNITY HEALTH, 36(4), 538-551.

In vivo MRSI of hyperpolarized [1-C-13]pyruvate metabolism in rat hepatocellular carcinoma
Darpolor, M. M., Yen, Y.-F., Chua, M.-S., Xing, L., Clarke-Katzenberg, R. H., & Spielman, D. M. (2011). In vivo MRSI of hyperpolarized [1-C-13]pyruvate metabolism in rat hepatocellular carcinoma. NMR IN BIOMEDICINE, 24(5), 506-513.

Doing Good with Good OR: Supporting Cost-Effective Hepatitis B Interventions
Hutton, D. W., Brandeau, M. L., & So, S. K. (2011). Doing Good with Good OR: Supporting Cost-Effective Hepatitis B Interventions. INTERFACES, 41(3), 289-300.

Comparative Profiling of Primary Colorectal Carcinomas and Liver Metastases Identifies LEF1 as a Prognostic Biomarker
Lin, A. Y., Chua, M.-S., Choi, Y.-L., Yeh, W., Kim, Y. H., & Pollack, J. R. (2011). Comparative Profiling of Primary Colorectal Carcinomas and Liver Metastases Identifies LEF1 as a Prognostic Biomarker. PLOS ONE, 6(2).

Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
Wei, W., Chua, M.-S., Grepper, S., & So, S. K. (2011). Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. MOLECULAR CANCER, 10.

Disparities in Liver Cancer Incidence by Nativity, Acculturation, and Socioeconomic Status in California Hispanics and Asians
Chang, E. T., Yang, J., Alfaro-Velcamp, T., So, S. Ks., Glaser, S. L., & Gomez, S. L. (2010). Disparities in Liver Cancer Incidence by Nativity, Acculturation, and Socioeconomic Status in California Hispanics and Asians. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 19(12), 3106-3118.

Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo
Wei, W., Chua, M.-S., Grepper, S., & So, S. (2010). Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. INTERNATIONAL JOURNAL OF CANCER, 126(10), 2426-2436.

Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease
El-Serag, H., McGlynn, K. A., Graham, G. N., So, S., Howell, C. D., & Thiel, T. K. (2010). Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease. JOURNAL OF FAMILY PRACTICE, 59(4), S37-S42.

Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study
Chao, J., Chang, E. T., & So, S. Ks. (2010). Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study. BMC PUBLIC HEALTH.

Cost-Effectiveness of Nationwide Hepatitis B Catch-up Vaccination Among Children and Adolescents in China
Hutton, D. W., So, S. K., & Brandeau, M. L. (2010). Cost-Effectiveness of Nationwide Hepatitis B Catch-up Vaccination Among Children and Adolescents in China. HEPATOLOGY, 51(2), 405-414.

Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma
Yen, Y., So, S., Rose, M., Saif, M. W., Chu, E., & Cheng, Y.-C. (2009). Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma. ANTICANCER RESEARCH, 29(10), 4083-4092.

Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
Wei, W., Chua, M.-S., Grepper, S., & So, S. K. (2009). Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. MOLECULAR CANCER, 8.

The Jade Ribbon Campaign: A Model Program for Community Outreach and Education to Prevent Liver Cancer in Asian Americans
Chao, S. D., Chang, E. T., Le, P. V., Prapong, W., Kiernan, M., & So, S. Ks. (2009). The Jade Ribbon Campaign: A Model Program for Community Outreach and Education to Prevent Liver Cancer in Asian Americans. JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 11(4), 281-290.

Frequent Inactivation of Axon Guidance Molecule RGMA in Human Colon Cancer Through Genetic and Epigenetic Mechanisms
Li, V. Sw., Yuen, S. T., Chan, T. L., Yan, H. Hn., Law, W. L., & Leung, S. Y. (2009). Frequent Inactivation of Axon Guidance Molecule RGMA in Human Colon Cancer Through Genetic and Epigenetic Mechanisms. GASTROENTEROLOGY, 137(1), 176-187.

Stopping a Silent Killer in the Underserved Asian and Pacific Islander Community: A Chronic Hepatitis B and Liver Cancer Prevention Clinic by Medical Students
Lin, S. Y., Chang, E. T., & So, S. K. (2009). Stopping a Silent Killer in the Underserved Asian and Pacific Islander Community: A Chronic Hepatitis B and Liver Cancer Prevention Clinic by Medical Students. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 10(3), 383-386.

3 For Life: A Model Pilot Program to Prevent Hepatitis B Virus Infection and Liver Cancer in Asian and Pacific Islander Americans
Chang, E. T., Sue, E., Zola, J., & So, S. K. (2009). 3 For Life: A Model Pilot Program to Prevent Hepatitis B Virus Infection and Liver Cancer in Asian and Pacific Islander Americans. AMERICAN JOURNAL OF HEALTH PROMOTION, 23(3), 176-181.

Eliminating the Threat of Chronic Hepatitis B in the Asian and Pacific Islander Community: A Call to Action
Chao, S. D., Chang, E. T., & So, S. K. (2009). Eliminating the Threat of Chronic Hepatitis B in the Asian and Pacific Islander Community: A Call to Action. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 10(3), 507-512.

N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells
Yan, X., Chua, M.-S., Sun, H., & So, S. (2008). N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. CANCER LETTERS, 262(1), 133-142.

Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo
Yan, X., Chua, M.-S., He, J., & So, S. K. (2008). Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. MOLECULAR CANCER, 7.

Phase H study of imatinib in unresectable hepatocellular carcinoma
Lin, A. Y., Fisher, G. A., So, S., Tang, C., & Levitt, L. (2008). Phase H study of imatinib in unresectable hepatocellular carcinoma. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 31(1), 84-88.

Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma.
Sun, H., Chua, M. S., Yang, D., Tsalenko, A., Peter, B. J., & So, S. (2008). Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma. Biomarker insights, 3, 1-18.

Attitudes toward Hepatitis B and Liver Cancer Prevention among Chinese Americans in the San Francisco Bay Area, California
Chang, E. T., Nguyen, B. H., & So, S. Ks. (2008). Attitudes toward Hepatitis B and Liver Cancer Prevention among Chinese Americans in the San Francisco Bay Area, California. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 9(4), 605-613.

Building partnerships with Traditional Chinese Medicine Practitioners to increase hepatitis B awareness and prevention
Chang, E. T., Lin, S. Y., Sue, E., Bergin, M., Su, J., & So, S. Ks. (2007). Building partnerships with Traditional Chinese Medicine Practitioners to increase hepatitis B awareness and prevention. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 13(10), 1125-1127.

Re: "Ten largest racial and ethnic health disparities in the United States based on healthy people 2010 objectives"
Chang, E. T., & So, S. Ks. (2007). Re: "Ten largest racial and ethnic health disparities in the United States based on healthy people 2010 objectives". AMERICAN JOURNAL OF EPIDEMIOLOGY, 166(9), 1105-1106.

Cost-effectiveness of screening and vaccinating Asian and pacific islander adults for hepatitis B
Hutton, D. W., Tan, D., So, S. K., & Brandeau, M. L. (2007). Cost-effectiveness of screening and vaccinating Asian and pacific islander adults for hepatitis B. ANNALS OF INTERNAL MEDICINE, 147(7), 460-469.

Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of Asians in California
Lin, S. Y., Chang, E. T., & So, S. K. (2007). Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of Asians in California. HEPATOLOGY, 46(4), 1034-1040.

The burden of liver cancer in Asians and Pacific Islanders in the greater San Francisco Bay Area, 1990 through 2004
Chang, E. T., Keegan, T. Hm., Gomez, S. L., Le, G. M., Clarke, C. A., & Glaser, S. L. (2007). The burden of liver cancer in Asians and Pacific Islanders in the greater San Francisco Bay Area, 1990 through 2004. CANCER, 109(10), 2100-2108.

Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma
Chua, M.-S., Sun, H., Cheung, S. T., Mason, V., Higgins, J., & So, S. (2007). Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. MODERN PATHOLOGY, 20(1), 76-83.

Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California
Wu, C. A., Lin, S. Y., So, S. K., & Chang, E. T. (2007). Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 8(1), 127-134.

Comprehensive analysis of 19q12 amplicon in human gastric cancers
Leung, S. Y., Ho, C., Tu, I.-P., Li, R., So, S., & Chen, X. (2006). Comprehensive analysis of 19q12 amplicon in human gastric cancers. MODERN PATHOLOGY, 19(6), 854-863.

Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma
Chua, M.-S., Bernstein, L. R., Li, R., & So, S. Ks. (2006). Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. ANTICANCER RESEARCH, 26(3A), 1739-1743.

Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma
Fong, C. W., Chua, M. S., McKie, A. B., Ling, S. Hm., Mason, L., & Guy, G. R. (2006). Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. CANCER RESEARCH, 66(4), 2048-2058.

Topological and functional discovery in a gene coexpression meta-network of gastric cancer
Aggarwal, A., Guo, D. L., Hoshida, Y., Yuen, S. T., Chu, K. M., & Tan, P. (2006). Topological and functional discovery in a gene coexpression meta-network of gastric cancer. CANCER RESEARCH, 66(1), 232-241.

Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma
Patil, M. A., Gutgemann, I., Zhang, J., Ho, C., Cheung, S. T., & Chen, X. (2005). Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. CARCINOGENESIS, 26(12), 2050-2057.

Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment
Hsu, C. P., Razavi, M. K., So, S. K., Parachikov, I. H., & Benaron, D. A. (2005). Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 16(11), 1473-1478.

An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma
Patil, M. A., Chua, M. S., Pan, K. H., Lin, R., Lih, C. J., & So, S. (2005). An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. ONCOGENE, 24(23), 3737-3747.

Mutations of PIK3CA in gastric adenocarcinoma
Li, V. Sw., Wong, C. W., Chan, T. L., Chan, A. Sw., Zhao, W., & Leung, S. Y. (2005). Mutations of PIK3CA in gastric adenocarcinoma. BMC CANCER, 5.

Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy
Cheung, S. T., Ho, J. Cy., Leung, K. L., Chen, X., Fong, D. Yt., & Fan, S. T. (2005). Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy. NEOPLASIA, 7(2), 91-98.

Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma
Cheung, S. T., Leung, K. L., Ip, Y. C., Chen, X., FONG, D. Y., & So, S. (2005). Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. CLINICAL CANCER RESEARCH, 11(2), 551-556.

Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma
Lin, A. Y., Brophy, N., Fisher, G. A., So, S., Biggs, C., & Levitt, L. (2005). Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma. CANCER, 103(1), 119-125.

Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma
Cheung, S. T., Wong, S. Y., Leung, K. L., Chen, X., So, S., & Fan, S. T. (2004). Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. CLINICAL CANCER RESEARCH, 10(22), 7629-7636.

High prevalence of chronic hepatitis B (HBV) infection in adult Chinese Americans living in California.
Chao, S., Le, P. V., Prapong, W., Su, J., & So, S. (2004). High prevalence of chronic hepatitis B (HBV) infection in adult Chinese Americans living in California. HEPATOLOGY, 40(4), 717A-717A.

Novel endothelial cell markers in hepatocellular carcinoma
Chen, X., Higgins, J., Cheung, S. T., Li, R., Mason, V., & So, S. (2004). Novel endothelial cell markers in hepatocellular carcinoma. MODERN PATHOLOGY, 17(10), 1198-1210.

Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer
Leung, S. Y., Yuen, S. T., Chu, K. M., Mathy, J. A., Li, R., & So, S. (2004). Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. GASTROENTEROLOGY, 127(2), 457-469.

One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: A single-center experience
Millan, M. T., Berquist, W. E., So, S. K., Sarwal, M. M., Wayman, K. I., & Esquivel, C. O. (2003). One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: A single-center experience. TRANSPLANTATION, 76(10), 1458-1463.

Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma
Chan, A. Sw., Tsui, W. Y., Chen, X., Chu, K. M., Chan, T. L., & Leung, S. Y. (2003). Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. ONCOGENE, 22(44), 6946-6953.

Variation in gene expression patterns in human gastric cancers
Chen, X., Leung, S. Y., Yuen, S. T., Chu, K. M., Ji, J. F., & Brown, P. O. (2003). Variation in gene expression patterns in human gastric cancers. MOLECULAR BIOLOGY OF THE CELL, 14(8), 3208-3215.

Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis
Leung, S. Y., Chen, X., Chu, K. M., Yuen, S. T., Mathy, J., & Brown, P. O. (2002). Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99(25), 16203-16208.

Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines
Ji, J. F., Chen, X., Leung, S. Y., Chi, J. Ta., Chu, K. M., & So, S. (2002). Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. ONCOGENE, 21(42), 6549-6556.

Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion.
Kim, P., Prapong, W., Sze, D. Y., So, S. K., & Razavi, M. K. (2002). Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Techniques in vascular and interventional radiology, 5(3), 127-131.

Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor
Cheung, S. T., Chen, X., GUAN, X. Y., Wong, S. Y., Tai, L. S., & Fan, S. T. (2002). Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. CANCER RESEARCH, 62(16), 4711-4721.

Gene expression patterns in human liver cancers
Chen, X., Cheung, S. T., So, S., Fan, S. T., Barry, C., & Brown, P. O. (2002). Gene expression patterns in human liver cancers. MOLECULAR BIOLOGY OF THE CELL, 13(6), 1929-1939.

Epstein-Barr virus infection is associated with endothelial bcl-2 expression in transplant liver allografts
Millan, M. T., Natkunam, Y., Clarke-Katzenberg, R., Desai, D., Prapong, W., & Martinez, O. M. (2002). Epstein-Barr virus infection is associated with endothelial bcl-2 expression in transplant liver allografts. TRANSPLANTATION, 73(3), 465-469.

Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma
Sze, D. Y., Razavi, M. K., So, S. Ks., & Jeffrey, R. B. (2001). Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma. AMERICAN JOURNAL OF ROENTGENOLOGY, 177(6), 1339-1345.

Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 outcomes
Kane, R., Solomon, H., Friedman, B., Heffron, T., DePaolo, J., & Spaith, E. (2001). Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 outcomes. TRANSPLANTATION, 72(3), 463-476.

Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis
Lai, K. M., MILLAN, M., Razavi, M., Keeffe, E. B., Prapong, W., & So, S. Ks. (2001). Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1490-1491.

CMV and EBV-PTLD after liver transplantation
So, S. (2001). CMV and EBV-PTLD after liver transplantation. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1317-1319.

A 100% 2-year graft survival can be attained in high-risk 15-kg or smaller infant recipients of kidney allografts
Millan, M. T., Sarwal, M. M., Lemley, K. V., Yorgin, P., Orlandi, P., & Salvatierra, O. (2000). A 100% 2-year graft survival can be attained in high-risk 15-kg or smaller infant recipients of kidney allografts. ARCHIVES OF SURGERY, 135(9), 1063-1068.

Liver transplantation for hepatocellular carcinoma and the role of preoperative chemoembolization.
Millan, M. T., Lai, K. M., Keeffe, E. B., Fisher, G. A., Razavi, M. K., & So, S. Ks. (2000). Liver transplantation for hepatocellular carcinoma and the role of preoperative chemoembolization. TRANSPLANTATION, 69(8), S215-S215.

Intravenous ribavirin therapy for adenovirus pneumonia
Shetty, A. K., Gans, H. A., So, S., Millan, M. T., Arvin, A. M., & Gutierrez, K. M. (2000). Intravenous ribavirin therapy for adenovirus pneumonia. PEDIATRIC PULMONOLOGY, 29(1), 69-73.

Significance of detecting Epstein-Barr-Specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients
Krieger, N. R., Martinez, O. M., Krams, S. M., Cox, K., So, S., & Esquivel, C. O. (2000). Significance of detecting Epstein-Barr-Specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients. LIVER TRANSPLANTATION, 6(1), 62-66.

CD81 gene expression is lost in hepatocellular carcinoma.
Drazan, K. E., Higgins, J., Fisher, G. A., Keefe, E., Barry, C. T., & Esquivel, C. O. (1999). CD81 gene expression is lost in hepatocellular carcinoma. HEPATOLOGY, 30(4), 248A-248A.

Resection versus transplantation for hepatocellular carcinoma
Esquivel, C. O., Keeffe, E. B., Garcia, G., Imperial, J. C., Millan, M. T., & So, S. K. (1999). Resection versus transplantation for hepatocellular carcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 14, S37-S41.

Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?
So, S. K., Esquivel, C. O., Imperial, J. C., Garcia, G., Monge, H., & Keeffe, E. B. (1999). Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 14, S48-S52.

Major hepatic resection without blood transfusion: Experience with total vascular exclusion
So, S. K., Monge, H., & Esquivel, C. O. (1999). Major hepatic resection without blood transfusion: Experience with total vascular exclusion. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 14, S28-S31.

Genomic analysis of human hepatocellular carcinoma gene expression using cDNA microarrays.
Barry, C. T., MILLAN, M., Monge, H., Esquivel, C., BROWN, P., & So, S. (1999). Genomic analysis of human hepatocellular carcinoma gene expression using cDNA microarrays. TRANSPLANTATION, 67(7), S142-S142.

Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
Cao, S., Cox, K. L., Berquist, W., Hayashi, M., Concepcion, W., & Esquivel, C. O. (1999). Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Pediatric transplantation, 3(1), 22-26.

Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation
Cacciarelli, T. V., Keeffe, E. B., Moore, D. H., BURNS, W., Busque, S., & Esquivel, C. O. (1999). Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. ARCHIVES OF SURGERY, 134(1), 25-29.

Increased dosage requirement and rejection after neoral conversion in pediatric liver transplant patients
Cao, S., Cox, K. L., Berquist, W., So, S., Concepcion, W., & Esquivel, C. O. (1998). Increased dosage requirement and rejection after neoral conversion in pediatric liver transplant patients. TRANSPLANTATION PROCEEDINGS, 30(8), 4322-4324.

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.
Lucey, M. R., Brown, K. A., Everson, G. T., Fung, J. J., Gish, R., & Wiesner, R. H. (1998). Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation, 66(7), 956-962.

Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation
Cao, S., Cox, K., Esquivel, C. O., Berquist, W., Concepcion, W., & So, S. (1998). Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation. TRANSPLANTATION, 66(7), 851-856.

Combined viral prophylactic and immunosuppressive strategy in liver transplantation (OLT) for HBV cirrhosis
So, S. Ks., Esquivel, C. O., Imperial, J. C., Garcia, G., & Keeffe, E. B. (1998). Combined viral prophylactic and immunosuppressive strategy in liver transplantation (OLT) for HBV cirrhosis. HEPATOLOGY, 28(4), 346A-346A.

Liver transplantation in the first three months of life
Woodle, E. S., Millis, J. M., So, S. Ks., McDiarmid, S. V., Busuttil, R. W., & Thistlethwaite, J. R. (1998). Liver transplantation in the first three months of life. TRANSPLANTATION, 66(5), 606-609.

Allograft rejection after liver transplantation for autoimmune liver diseases
Hayashi, M., Keeffe, E. B., Krams, S. M., Martinez, O. M., Ojogho, O. N., & Esquivel, C. O. (1998). Allograft rejection after liver transplantation for autoimmune liver diseases. LIVER TRANSPLANTATION AND SURGERY, 4(3), 208-214.

Indications for pediatric liver transplantation.
McDiarmid, S. V., Millis, M. J., Olthoff, K. M., & So, S. K. (1998). Indications for pediatric liver transplantation. Pediatric transplantation, 2(2), 106-116.

Current status of living-related liver transplantation.
Hayashi, M., Cao, S., Concepcion, W., Monge, H., Ojogho, O., & Esquivel, C. O. (1998). Current status of living-related liver transplantation. Pediatric transplantation, 2(1), 16-25.

Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation
Busque, S., Esquivel, C. O., Concepcion, W., & So, S. Ks. (1998). Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. TRANSPLANTATION, 65(1), 77-82.

Liver transplantation at Stanford University Medical Center.
Millan, M. T., Keeffe, E. B., Berquist, W. E., Castillo, R. O., Cox, K. L., & Esquivel, C. O. (1998). Liver transplantation at Stanford University Medical Center. Clinical transplants, 287-296.

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.
Lucey, M. R., Brown, K. A., Everson, G. T., Fung, J. J., Gish, R., & Wiesner, R. H. (1997). Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver transplantation and surgery , 3(6), 628-637.

Transjugular intrahepatic portosystemic shunt placement in a child complicated by perforated Roux-en-Y portoenterostomy
Wang, J., Cox, K. L., Dake, M., Esquivel, C. O., & So, S. Ks. (1997). Transjugular intrahepatic portosystemic shunt placement in a child complicated by perforated Roux-en-Y portoenterostomy. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 25(4), 421-425.

Superior outcomes in pediatric renal transplantation
Salvatierra, O., Alfrey, E., Tanney, D. C., Mak, R., Hammer, G. B., & Conley, S. B. (1997). Superior outcomes in pediatric renal transplantation. ARCHIVES OF SURGERY, 132(8), 842-847.

Factors affecting survival after orthotopic liver transplantation in infants
Cacciarelli, T. V., Esquivel, C. O., Moore, D. H., Cox, K. L., Berquist, W. E., & So, S. Ks. (1997). Factors affecting survival after orthotopic liver transplantation in infants. TRANSPLANTATION, 64(2), 242-248.

Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients
Cao, S., Cox, K., So, S. Sk., Berquist, W., Lee, S. P., & Esquivel, C. O. (1997). Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients. DIGESTIVE DISEASES AND SCIENCES, 42(7), 1409-1415.

Orthotopic liver transplantation from non-heart-beating donor rats: Effect of flushing with cold/warm UW/SLS preservation solutions
Tojimbara, T., Winston, W. N., So, S. K., & Esquivel, C. O. (1997). Orthotopic liver transplantation from non-heart-beating donor rats: Effect of flushing with cold/warm UW/SLS preservation solutions. TRANSPLANTATION PROCEEDINGS, 29(1-2), 1371-1373.

Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: A case report
Cao, S., Monge, H., Semba, C., Cox, K. L., Berquist, W., & Esquivel, C. O. (1997). Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: A case report. JOURNAL OF PEDIATRIC SURGERY, 32(1), 125-127.

Liver transplantation in Asian patients with chronic hepatitis B
HO, B. M., So, S. K., Esquivel, C. O., & Keeffe, E. B. (1997). Liver transplantation in Asian patients with chronic hepatitis B. HEPATOLOGY, 25(1), 223-225.

Primary liver transplantation without transfusion of red blood cells
Cacciarelli, T. V., Keeffe, E. B., Moore, D. H., BURNS, W., Chuljian, P., & Esquivel, C. O. (1996). Primary liver transplantation without transfusion of red blood cells. SURGERY, 120(4), 698-704.

Orthotopic liver transplantation for hepatocellular carcinoma - Factors affecting long-term patient survival
Ojogho, O. N., So, S. Ks., Keeffe, E. B., Berquist, W., Concepcion, W., & Esquivel, C. O. (1996). Orthotopic liver transplantation for hepatocellular carcinoma - Factors affecting long-term patient survival. ARCHIVES OF SURGERY, 131(9), 935-939.

Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting - Bridge to liver transplantation
Hammer, G. B., So, S. Ks., ALUZRI, A., Conley, S. B., Concepcion, W., & Esquivel, C. O. (1996). Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting - Bridge to liver transplantation. TRANSPLANTATION, 62(1), 130-132.

Cyclosporine and tacrolimus both suppress activation of kupffer cells in vitro
Tojimbara, T., Bermudez, L. E., Egawa, H., Hayashi, M., So, S. K., & Esquivel, C. O. (1996). Cyclosporine and tacrolimus both suppress activation of kupffer cells in vitro. TRANSPLANTATION PROCEEDINGS, 28(3), 1381-1382.

Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation
Cacciarelli, T. V., Esquivel, C. O., Cox, K. L., Hayashi, M., Berquist, W. E., & So, S. Ks. (1996). Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. TRANSPLANTATION, 61(8), 1188-1192.

Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients
Esquivel, C. O., So, S. K., McDiarmid, S. V., Andrews, W. S., & Colombani, P. M. (1996). Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. TRANSPLANTATION, 61(5), 847-848.

Expression of cytokines and immune mediators during chronic liver allograft rejection
Hayashi, M., Martinez, O. M., GARCIAKENNEDY, R., So, S., Esquivel, C. O., & Krams, S. M. (1995). Expression of cytokines and immune mediators during chronic liver allograft rejection. TRANSPLANTATION, 60(12), 1533-1538.

THE USE OF NON-HEART-BEATING CADAVER DONORS IN EXPERIMENTAL LIVER-TRANSPLANTATION
Tojimbara, T., Kennedy, R. G., BURNS, W., Hayashi, M., Krams, S., & Esquivel, C. O. (1995). THE USE OF NON-HEART-BEATING CADAVER DONORS IN EXPERIMENTAL LIVER-TRANSPLANTATION. TRANSPLANTATION, 60(10), 1179-1180.

FULMINANT HEPATIC-FAILURE FOLLOWING VARICELLA-ZOSTER INFECTION IN A CHILD - A CASE-REPORT OF SUCCESSFUL TREATMENT WITH LIVER-TRANSPLANTATION AND PERIOPERATIVE ACYCLOVIR
Tojimbara, T., So, S. K., Cox, K. L., Berquist, W. E., Egawa, H., & Esquivel, C. O. (1995). FULMINANT HEPATIC-FAILURE FOLLOWING VARICELLA-ZOSTER INFECTION IN A CHILD - A CASE-REPORT OF SUCCESSFUL TREATMENT WITH LIVER-TRANSPLANTATION AND PERIOPERATIVE ACYCLOVIR. TRANSPLANTATION, 60(9), 1052-1053.

A REASSESSMENT OF ABO INCOMPATIBILITY IN PEDIATRIC LIVER-TRANSPLANTATION
Cacciarelli, T. V., So, S. Ks., Lim, J., Concepcion, W., Cox, K., & Esquivel, C. O. (1995). A REASSESSMENT OF ABO INCOMPATIBILITY IN PEDIATRIC LIVER-TRANSPLANTATION. TRANSPLANTATION, 60(7), 757-760.

LIVER-TRANSPLANTATION IN A CHILD WITH SICKLE-CELL-ANEMIA
Lang, T., Berquist, W. E., So, S. K., Cox, K. L., RICH, E. J., & Esquivel, C. O. (1995). LIVER-TRANSPLANTATION IN A CHILD WITH SICKLE-CELL-ANEMIA. TRANSPLANTATION, 59(10), 1490-1492.

EFFECTS OF PENTOXIFYLLINE PRETREATMENT ON KUPFFER CELLS IN RAT-LIVER TRANSPLANTATION
Kozaki, K., Egawa, H., Bermudez, L., Keefe, E. B., So, S. K., & Esquivel, C. O. (1995). EFFECTS OF PENTOXIFYLLINE PRETREATMENT ON KUPFFER CELLS IN RAT-LIVER TRANSPLANTATION. HEPATOLOGY, 21(4), 1079-1082.

ISOLATED ALKALINE PHOSPHATEMIA FOLLOWING PEDIATRIC LIVER-TRANSPLANTATION IN THE FK506 ERA
Egawa, H., Berquist, W., So, S. K., Cox, K., Menegaux, F., & Esquivel, C. O. (1995). ISOLATED ALKALINE PHOSPHATEMIA FOLLOWING PEDIATRIC LIVER-TRANSPLANTATION IN THE FK506 ERA. TRANSPLANTATION, 59(5), 791-793.

DIFFERENTIAL PATTERNS OF CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (CICAM-1) AND VASCULAR CELL-ADHESION MOLECULE-1 (CVCAM-1) DURING LIVER ALLOGRAFT-REJECTION
Lang, T., Krams, S. M., Villanueva, J. C., Cox, K., So, S., & Martinez, O. M. (1995). DIFFERENTIAL PATTERNS OF CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (CICAM-1) AND VASCULAR CELL-ADHESION MOLECULE-1 (CVCAM-1) DURING LIVER ALLOGRAFT-REJECTION. TRANSPLANTATION, 59(4), 584-589.

FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER-TRANSPLANTATION - RESULTS FROM THE US MULTICENTER TRIAL
McDiarmid, S. V., Busuttil, R. W., Ascher, N. L., Burdick, J., DALESSANDRO, A. M., & So, S. K. (1995). FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER-TRANSPLANTATION - RESULTS FROM THE US MULTICENTER TRIAL. TRANSPLANTATION, 59(4), 530-536.

AN INCREASED INCIDENCE OF EPSTEIN-BARR-VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG-CHILDREN ON FK506 AFTER LIVER-TRANSPLANTATION
Cox, K. L., LAWRENCEMIYASAKI, L. S., GARCIAKENNEDY, R., Lennette, E. T., Martinez, O. M., & Esquivel, C. O. (1995). AN INCREASED INCIDENCE OF EPSTEIN-BARR-VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG-CHILDREN ON FK506 AFTER LIVER-TRANSPLANTATION. TRANSPLANTATION, 59(4), 524-529.

IMPACT OF REDUCED-SIZE LIVER-TRANSPLANTATION ON REJECTION AND LIVER ALLOGRAFT OUTCOME IN THE PEDIATRIC POPULATION
Cacciarelli, T. V., So, S. Ks., Egawa, H., Cox, K., & Esquivel, C. O. (1995). IMPACT OF REDUCED-SIZE LIVER-TRANSPLANTATION ON REJECTION AND LIVER ALLOGRAFT OUTCOME IN THE PEDIATRIC POPULATION. TRANSPLANTATION PROCEEDINGS, 27(1), 1239-1240.

CHARACTERIZATION OF CYTOKINE EXPRESSION IN AN ANIMAL-MODEL OF ACUTE LIVER ALLOGRAFT-REJECTION
Egawa, H., Martinez, O. M., QUINN, M. B., So, S., Esquivel, C. O., & Krams, S. M. (1995). CHARACTERIZATION OF CYTOKINE EXPRESSION IN AN ANIMAL-MODEL OF ACUTE LIVER ALLOGRAFT-REJECTION. TRANSPLANTATION PROCEEDINGS, 27(1), 505-506.

FK-506 RESCUE THERAPY FOR HEPATIC ALLOGRAFT-REJECTION - EXPERIENCE WITH AN AGGRESSIVE APPROACH
Woodle, E. S., Perdrizet, G. A., So, S. Ks., White, H. M., & Marsh, J. W. (1995). FK-506 RESCUE THERAPY FOR HEPATIC ALLOGRAFT-REJECTION - EXPERIENCE WITH AN AGGRESSIVE APPROACH. CLINICAL TRANSPLANTATION, 9(1), 45-52.

LONG-TERM NONRESPONSIVENESS TO A LIVER ALLOGRAFT MAY BE CYTOKINE-MEDIATED
Egawa, H., Martinez, O. M., QUINN, M. B., Villanueva, J. C., So, S., & Krams, S. M. (1995). LONG-TERM NONRESPONSIVENESS TO A LIVER ALLOGRAFT MAY BE CYTOKINE-MEDIATED. TRANSPLANTATION PROCEEDINGS, 27(1), 241-242.

DISTINCT PATTERNS OF TH2 CYTOKINE PRODUCTION DURING IMMUNE ACTIVATION IN PEDIATRIC LIVER ALLOGRAFT RECIPIENTS
Lang, T., Krams, S. M., Villanueva, J. C., Cox, K., So, S., & Martinez, O. M. (1995). DISTINCT PATTERNS OF TH2 CYTOKINE PRODUCTION DURING IMMUNE ACTIVATION IN PEDIATRIC LIVER ALLOGRAFT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 27(1), 1146-1147.

MOLECULAR MARKERS OF EPSTEIN-BARR-VIRUS INFECTION IN THE CIRCULATION OF TRANSPLANT RECIPIENTS
Martinez, O. M., Villanueva, J. C., LAWRENCEMIYASAKI, L., QUINN, M. B., Gish, R., & Krams, S. M. (1995). MOLECULAR MARKERS OF EPSTEIN-BARR-VIRUS INFECTION IN THE CIRCULATION OF TRANSPLANT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 27(1), 1211-1212.

CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 AND VASCULAR CELL-ADHESION MOLECULE-1 IN PEDIATRIC LIVER RECIPIENTS
Lang, T., Krams, S. M., Villanueva, J. C., So, S. K., Berquist, W. E., & Martinez, O. M. (1995). CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 AND VASCULAR CELL-ADHESION MOLECULE-1 IN PEDIATRIC LIVER RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 27(1), 1148-1149.

ACUTE LIVER ALLOGRAFT-REJECTION IN THE RAT - AN ANALYSIS OF THE IMMUNE RESPONSE
Egawa, H., Martinez, O. M., QUINN, M. B., Villanueva, J. C., So, S., & Krams, S. M. (1995). ACUTE LIVER ALLOGRAFT-REJECTION IN THE RAT - AN ANALYSIS OF THE IMMUNE RESPONSE. TRANSPLANTATION, 59(1), 97-102.

EX-VIVO TECHNIQUE FOR RIGHT LOBECTOMY IN PEDIATRIC HEPATIC TRANSPLANTATION
Wong, L., Concepcion, W., So, S. K., Egawa, H., Menegaux, F., & Esquivel, C. O. (1994). EX-VIVO TECHNIQUE FOR RIGHT LOBECTOMY IN PEDIATRIC HEPATIC TRANSPLANTATION. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 179(5), 601-603.

NEUROLOGICAL COMPLICATIONS OF LIVER-TRANSPLANTATION IN ADULT VERSUS PEDIATRIC-PATIENTS
Menegaux, F., Keeffe, E. B., Andrews, B. T., Egawa, H., Monge, H., & Esquivel, C. O. (1994). NEUROLOGICAL COMPLICATIONS OF LIVER-TRANSPLANTATION IN ADULT VERSUS PEDIATRIC-PATIENTS. TRANSPLANTATION, 58(4), 447-450.

RESPIRATORY-DISTRESS FROM BENIGN LIVER-TUMORS - A REPORT OF 2 UNUSUAL CASES TREATED WITH HEPATIC TRANSPLANTATION
Egawa, H., Berquist, W., GARCIAKENNEDY, R., Cox, K. L., Concepcion, W., & Esquivel, C. O. (1994). RESPIRATORY-DISTRESS FROM BENIGN LIVER-TUMORS - A REPORT OF 2 UNUSUAL CASES TREATED WITH HEPATIC TRANSPLANTATION. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 19(1), 114-117.

FK506 CONVERSION THERAPY IN PEDIATRIC LIVER-TRANSPLANTATION
Egawa, H., Esquivel, C. O., So, S. K., Cox, K., Concepcion, W., & Lawrence, L. (1994). FK506 CONVERSION THERAPY IN PEDIATRIC LIVER-TRANSPLANTATION. TRANSPLANTATION, 57(8), 1169-1173.

PREVENTION OF REJECTION AND GRAFT LOSS WITH AN AGGRESSIVE QUADRUPLE IMMUNOSUPPRESSIVE THERAPY REGIMEN IN CHILDREN AND ADOLESCENTS
Conley, S. B., ALUZRI, A., So, S., & Salvatierra, O. (1994). PREVENTION OF REJECTION AND GRAFT LOSS WITH AN AGGRESSIVE QUADRUPLE IMMUNOSUPPRESSIVE THERAPY REGIMEN IN CHILDREN AND ADOLESCENTS. TRANSPLANTATION, 57(4), 540-544.

INDUCTION IMMUNOSUPPRESSION WITH ANTILYMPHOCYTE GLOBULIN OR OKT3 IN CADAVER KIDNEY-TRANSPLANTATION
Hanto, D. W., Jendrisak, M. D., So, S. Ks., McCullough, C. S., Rush, T. M., & Mohanakumar, T. (1994). INDUCTION IMMUNOSUPPRESSION WITH ANTILYMPHOCYTE GLOBULIN OR OKT3 IN CADAVER KIDNEY-TRANSPLANTATION. TRANSPLANTATION, 57(3), 377-384.

AGGRESSIVE EARLY CYCLOSPORINE THERAPY IS DESIRABLE IN PEDIATRIC RENAL TRANSPLANTATION
ALUZRI, A., Conley, S. B., Orlandi, P., So, S., & Salvatierra, O. (1994). AGGRESSIVE EARLY CYCLOSPORINE THERAPY IS DESIRABLE IN PEDIATRIC RENAL TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 26(1), 88-90.

Liver transplantation at California Pacific Medical Center, San Francisco, California.
Esquivel, C. O., Martinez, O., Krams, S., Lim, J., So, S. K., & Keeffe, E. B. (1994). Liver transplantation at California Pacific Medical Center, San Francisco, California. Clinical transplants, 163-171.

PENTOXIFYLLINE INHIBITS PRODUCTION OF SUPEROXIDE ANION AND TUMOR-NECROSIS-FACTOR BY KUPFFER CELLS IN RAT-LIVER PRESERVATION
Kozaki, K., Egawa, H., BERMUDES, L., Feduska, N. J., So, S., & Esquivel, C. O. (1993). PENTOXIFYLLINE INHIBITS PRODUCTION OF SUPEROXIDE ANION AND TUMOR-NECROSIS-FACTOR BY KUPFFER CELLS IN RAT-LIVER PRESERVATION. TRANSPLANTATION PROCEEDINGS, 25(6), 3025-3026.

COMPARATIVE EFFECTS OF BLOOD, COLLOID, AND RINGERS LACTATE TERMINAL ALLOGRAFT RINSE ON THE RESULTS OF ORTHOTOPIC LIVER-TRANSPLANTATION
Menegaux, F., Egawa, H., Keeffe, E. B., So, S. K., Concepcion, W., & Esquivel, C. O. (1993). COMPARATIVE EFFECTS OF BLOOD, COLLOID, AND RINGERS LACTATE TERMINAL ALLOGRAFT RINSE ON THE RESULTS OF ORTHOTOPIC LIVER-TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 25(6), 3196-3198.

OKT3 REVERSAL OF BIOPSY-PROVEN ALLOGRAFT-REJECTION OCCURRING DURING MINNESOTA ANTILYMPHOBLAST GLOBULIN INDUCTION IN THE PEDIATRIC RENAL RECIPIENT
Bunchman, T. E., Kershaw, D. B., Merion, R. M., Ham, J. M., Sedman, A. B., & So, S. Ks. (1993). OKT3 REVERSAL OF BIOPSY-PROVEN ALLOGRAFT-REJECTION OCCURRING DURING MINNESOTA ANTILYMPHOBLAST GLOBULIN INDUCTION IN THE PEDIATRIC RENAL RECIPIENT. CLINICAL TRANSPLANTATION, 7(3), 219-222.

FK-506 RESCUE THERAPY - EARLY CONVERSION IMPROVES EFFICACY
Woodle, E. S., Perdrizet, G. A., So, S., Jendrisak, M. D., White, H. M., & Marsh, J. W. (1993). FK-506 RESCUE THERAPY - EARLY CONVERSION IMPROVES EFFICACY. TRANSPLANTATION PROCEEDINGS, 25(2), 1990-1991.

SUCCESSFUL RETRANSPLANTATION AFTER A 48-HOUR ANHEPATIC STATE
So, S. Ks., BARTEAU, J. A., Perdrizet, G. A., & Marsh, J. W. (1993). SUCCESSFUL RETRANSPLANTATION AFTER A 48-HOUR ANHEPATIC STATE. TRANSPLANTATION PROCEEDINGS, 25(2), 1962-1963.

FK-506 RESCUE THERAPY - THE RAPIDITY OF REJECTION REVERSAL IS RELATED TO THE SUBSEQUENT DEVELOPMENT OF CMV DISEASE
Woodle, E. S., Perdrizet, G. A., So, S., Jendrisak, M. D., White, H. M., & Marsh, J. W. (1993). FK-506 RESCUE THERAPY - THE RAPIDITY OF REJECTION REVERSAL IS RELATED TO THE SUBSEQUENT DEVELOPMENT OF CMV DISEASE. TRANSPLANTATION PROCEEDINGS, 25(2), 1992-1993.

RECURRENT REJECTION FOLLOWING FK-506 RESCUE THERAPY FOR ACUTE HEPATIC ALLOGRAFT-REJECTION
Woodle, E. S., So, S., Jendrisak, M. D., Perdrizet, G. A., White, H. M., & Marsh, J. W. (1993). RECURRENT REJECTION FOLLOWING FK-506 RESCUE THERAPY FOR ACUTE HEPATIC ALLOGRAFT-REJECTION. TRANSPLANTATION PROCEEDINGS, 25(2), 1988-1989.

INTRAHEPATIC PORTOSYSTEMIC VASCULAR STENTS - A BRIDGE TO HEPATIC TRANSPLANTATION
Woodle, E. S., Darcy, M., White, H. M., Perdrizet, G. A., Vesely, T. M., & Marsh, J. W. (1993). INTRAHEPATIC PORTOSYSTEMIC VASCULAR STENTS - A BRIDGE TO HEPATIC TRANSPLANTATION. SURGERY, 113(3), 344-351.

CYTOMEGALOVIRUS PROPHYLAXIS IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
So, S., Mayo, C., McCullough, C., Jendrisak, M., Woodle, S., & Bailey, T. (1993). CYTOMEGALOVIRUS PROPHYLAXIS IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 25(1), 1414-1415.

FK506 - INHIBITION OF HUMORAL MECHANISMS OF HEPATIC ALLOGRAFT-REJECTION
Woodle, E. S., Perdrizet, G. A., Brunt, E. M., So, S. Ks., Jendrisak, M. D., & Marsh, J. W. (1992). FK506 - INHIBITION OF HUMORAL MECHANISMS OF HEPATIC ALLOGRAFT-REJECTION. TRANSPLANTATION, 54(2), 377-381.

EARLY OCCURRENCE OF END-STAGE RENAL-DISEASE IN A PATIENT WITH INFANTILE NEPHROPATHIC CYSTINOSIS
Schnaper, H. W., COTTEL, J., Merrill, S., Marcusson, E., Kissane, J. M., & Schneider, J. A. (1992). EARLY OCCURRENCE OF END-STAGE RENAL-DISEASE IN A PATIENT WITH INFANTILE NEPHROPATHIC CYSTINOSIS. JOURNAL OF PEDIATRICS, 120(4), 575-578.

QT PROLONGATION AND TORSADES-DE-POINTES AFTER ADMINISTRATION OF FK506
Johnson, M. C., So, S., Marsh, J. W., & Murphy, A. M. (1992). QT PROLONGATION AND TORSADES-DE-POINTES AFTER ADMINISTRATION OF FK506. TRANSPLANTATION, 53(4), 929-930.

FK-506 - REVERSAL OF HUMORALLY MEDIATED REJECTION FOLLOWING ABO-INCOMPATIBLE LIVER-TRANSPLANTATION
Woodle, E. S., Perdrizet, G. A., Brunt, E. M., So, S. Ks., Jendrisak, M. D., & Marsh, J. W. (1991). FK-506 - REVERSAL OF HUMORALLY MEDIATED REJECTION FOLLOWING ABO-INCOMPATIBLE LIVER-TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 23(6), 2992-2993.

ANESTHETIC MANAGEMENT OF INFANTS RECEIVING AN ADULT KIDNEY-TRANSPLANT
Beebe, D. S., Belani, K. G., MERGENS, P., Liao, J. C., So, S. Ks., & PALAHNIUK, R. J. (1991). ANESTHETIC MANAGEMENT OF INFANTS RECEIVING AN ADULT KIDNEY-TRANSPLANT. ANESTHESIA AND ANALGESIA, 73(6), 725-730.

RENAL-TRANSPLANTATION FOR SYSTEMIC LUPUS-ERYTHEMATOSUS AND RECURRENT LUPUS NEPHRITIS - A SINGLE-CENTER EXPERIENCE AND A REVIEW OF THE LITERATURE
Goss, J. A., Cole, B. R., Jendrisak, M. D., McCullough, C. S., So, S. Ks., & Hanto, D. W. (1991). RENAL-TRANSPLANTATION FOR SYSTEMIC LUPUS-ERYTHEMATOSUS AND RECURRENT LUPUS NEPHRITIS - A SINGLE-CENTER EXPERIENCE AND A REVIEW OF THE LITERATURE. TRANSPLANTATION, 52(5), 805-810.

LAPAROSCOPIC DRAINAGE OF A POSTTRANSPLANT LYMPHOCELE
McCullough, C. S., Soper, N. J., Clayman, R. V., So, S. Sk., Jendrisak, M. D., & Hanto, D. W. (1991). LAPAROSCOPIC DRAINAGE OF A POSTTRANSPLANT LYMPHOCELE. TRANSPLANTATION, 51(3), 725-727.

SHORT-TERM AND LONG-TERM EFFECTS OF HLA MATCHING IN CADAVERIC PANCREAS TRANSPLANTATION
So, S. Ks., MOUDRYMUNNS, K. C., Gillingham, K., Minford, E. J., & Sutherland, D. Er. (1991). SHORT-TERM AND LONG-TERM EFFECTS OF HLA MATCHING IN CADAVERIC PANCREAS TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 23(1), 1634-1636.

SUCCESSFUL KIDNEY-TRANSPLANTATION IN INFANTS
Najarian, J. S., Frey, D. J., Matas, A. J., So, S. Ks., Cook, M., & Nevins, T. E. (1991). SUCCESSFUL KIDNEY-TRANSPLANTATION IN INFANTS. TRANSPLANTATION PROCEEDINGS, 23(1), 1382-1383.

A PROSPECTIVE RANDOMIZED COMPARISON OF PROPHYLACTIC ALG AND OKT3 IN CADAVER KIDNEY ALLOGRAFT RECIPIENTS
Hanto, D. W., Jendrisak, M. D., McCullough, C. S., So, S. Ks., Marsh, J. W., & Mohanakumar, T. (1991). A PROSPECTIVE RANDOMIZED COMPARISON OF PROPHYLACTIC ALG AND OKT3 IN CADAVER KIDNEY ALLOGRAFT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 23(1), 1050-1051.

SIGNIFICANCE OF B-CELL CROSS-MATCH ON OUTCOME IN RENAL-TRANSPLANTATION
Jendrisak, M., Phelan, D., Marsh, J., McCullough, C., So, S., & Hanto, D. (1991). SIGNIFICANCE OF B-CELL CROSS-MATCH ON OUTCOME IN RENAL-TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 23(1), 434-436.

THE USE OF CADAVER KIDNEYS FOR TRANSPLANTATION IN YOUNG-CHILDREN
So, S. Ks., Gillingham, K., Cook, M., Mauer, S. M., Matas, A., & Najarian, J. S. (1990). THE USE OF CADAVER KIDNEYS FOR TRANSPLANTATION IN YOUNG-CHILDREN. TRANSPLANTATION, 50(6), 979-983.

RENAL-TRANSPLANTATION IN INFANTS
Najarian, J. S., Frey, D. J., Matas, A. J., Gillingham, K. J., So, S. Sk., & Nevins, T. E. (1990). RENAL-TRANSPLANTATION IN INFANTS. ANNALS OF SURGERY, 212(3), 353-367.

REVERSIBLE HEPATIC TRANSPLANT ISCHEMIA - CASE-REPORT AND REVIEW OF LITERATURE
Castaneda, F., So, S. Ks., Hunter, D. W., CASTANEDAZUNIGA, W. R., & Amplatz, K. (1990). REVERSIBLE HEPATIC TRANSPLANT ISCHEMIA - CASE-REPORT AND REVIEW OF LITERATURE. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 13(2), 88-90.

DR MATCHING IMPROVES CADAVERIC PANCREAS TRANSPLANT RESULTS
So, S. Ks., Minford, E. J., MOUDRYMUNNS, K. C., Gillingham, K., & Sutherland, D. Er. (1990). DR MATCHING IMPROVES CADAVERIC PANCREAS TRANSPLANT RESULTS. TRANSPLANTATION PROCEEDINGS, 22(2), 687-688.

INVITRO IMMUNOSUPPRESSIVE EFFECTS OF MURINE HEPATOCYTE CYTOSOL
Bumgardner, G. L., Billiar, T., So, S. K., Chen, S., Dunn, G., & Ascher, N. L. (1989). INVITRO IMMUNOSUPPRESSIVE EFFECTS OF MURINE HEPATOCYTE CYTOSOL. TRANSPLANTATION PROCEEDINGS, 21(1), 1154-1155.

AFFERENT AND EFFERENT PATHWAYS IN T-CELL RESPONSES TO MHC CLASS I+, II-HEPATOCYTES
Bumgardner, G. L., Chen, S., Hoffman, R., Cahill, D. C., So, S. K., & Ascher, N. L. (1989). AFFERENT AND EFFERENT PATHWAYS IN T-CELL RESPONSES TO MHC CLASS I+, II-HEPATOCYTES. TRANSPLANTATION, 47(1), 163-170.

LOW-DOSE CYCLOSPORINE THERAPY COMBINED WITH STANDARD IMMUNOSUPPRESSION IN PEDIATRIC RENAL-TRANSPLANTATION
So, S. Ks., Najarian, J. S., Nevins, T. E., FRYD, D. S., Knaak, M., & SIMMONS, R. L. (1987). LOW-DOSE CYCLOSPORINE THERAPY COMBINED WITH STANDARD IMMUNOSUPPRESSION IN PEDIATRIC RENAL-TRANSPLANTATION. JOURNAL OF PEDIATRICS, 111(6), 1017-1021.

MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ANTIGENS ON HEPATOCYTES IN HUMAN-LIVER GRAFTS
Platt, J. L., Ascher, N. L., Snover, D. C., & So, S. Ks. (1987). MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ANTIGENS ON HEPATOCYTES IN HUMAN-LIVER GRAFTS. TRANSPLANTATION PROCEEDINGS, 19(4), 66-67.

DIALYSIS ACCESS - RADIOGRAPHIC EVALUATION AND MANAGEMENT
Hunter, D. W., & So, S. K. (1987). DIALYSIS ACCESS - RADIOGRAPHIC EVALUATION AND MANAGEMENT. RADIOLOGIC CLINICS OF NORTH AMERICA, 25(2), 249-260.

GROWTH AND DEVELOPMENT IN INFANTS AFTER RENAL-TRANSPLANTATION
So, S. Ks., Chang, P. N., Najarian, J. S., Mauer, S. M., SIMMONS, R. L., & Nevins, T. E. (1987). GROWTH AND DEVELOPMENT IN INFANTS AFTER RENAL-TRANSPLANTATION. JOURNAL OF PEDIATRICS, 110(3), 343-350.

1ST KIDNEY-TRANSPLANTS IN CHILDREN 5 YEARS OF AGE OR YOUNGER
Najarian, J. S., So, S. Ks., SIMMONS, R. L., Mauer, S. M., Nevins, T. E., & FRYD, D. S. (1987). 1ST KIDNEY-TRANSPLANTS IN CHILDREN 5 YEARS OF AGE OR YOUNGER. TRANSPLANTATION PROCEEDINGS, 19(1), 2111-2112.

PURIFIED HEPATOCYTES CAN STIMULATE ALLOSPECIFIC CYTOLYTIC LYMPHOCYTES-T IN A MIXED LYMPHOCYTE-HEPATOCYTE CULTURE
So, S. Ks., Wilkes, L. M., Platt, J. L., Ascher, N. L., & SIMMONS, R. L. (1987). PURIFIED HEPATOCYTES CAN STIMULATE ALLOSPECIFIC CYTOLYTIC LYMPHOCYTES-T IN A MIXED LYMPHOCYTE-HEPATOCYTE CULTURE. TRANSPLANTATION PROCEEDINGS, 19(1), 251-252.

CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ARE INDUCED ON HEPATOCYTES IN REJECTING HUMAN-LIVER GRAFTS
So, S. Ks., Snover, D. C., Ascher, N. L., & Platt, J. L. (1987). CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ARE INDUCED ON HEPATOCYTES IN REJECTING HUMAN-LIVER GRAFTS. TRANSPLANTATION PROCEEDINGS, 19(1), 2464-2465.

A COMPARISON OF 3 IMMUNOSUPPRESSIVE PROTOCOLS IN PATIENTS AGED OVER 50 YEARS
FRYD, D. S., So, S. Ks., Kruse, L., Canafax, D. M., Sutherland, D. Er., & Najarian, J. S. (1987). A COMPARISON OF 3 IMMUNOSUPPRESSIVE PROTOCOLS IN PATIENTS AGED OVER 50 YEARS. TRANSPLANTATION PROCEEDINGS, 19(1), 1530-1531.

INCREASED EXPRESSION OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ON HEPATOCYTES IN REJECTING HUMAN-LIVER ALLOGRAFTS
So, S. Ks., Platt, J. L., Ascher, N. L., & Snover, D. C. (1987). INCREASED EXPRESSION OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ON HEPATOCYTES IN REJECTING HUMAN-LIVER ALLOGRAFTS. TRANSPLANTATION, 43(1), 79-85.

Renal transplantation at the University of Minnesota during the 1980s.
FRYD, D. S., MIGLIORI, R., SIMMONS, R. L., Chavers, B., Dunn, D., & Mauer, S. M. (1987). Renal transplantation at the University of Minnesota during the 1980s. Clinical transplants, 167-181.

THE OUTCOME OF 304 PRIMARY RENAL-TRANSPLANTS IN CHILDREN (1968-1985)
Najarian, J. S., So, S. Ks., SIMMONS, R. L., FRYD, D. S., Nevins, T. E., & Mauer, S. M. (1986). THE OUTCOME OF 304 PRIMARY RENAL-TRANSPLANTS IN CHILDREN (1968-1985). ANNALS OF SURGERY, 204(3), 246-258.

CURRENT RESULTS IN PEDIATRIC RENAL-TRANSPLANTATION AT THE UNIVERSITY-OF-MINNESOTA
So, S. Ks., Mauer, S. M., Nevins, T. E., FRYD, D. S., Sutherland, D. Er., & Najarian, J. S. (1986). CURRENT RESULTS IN PEDIATRIC RENAL-TRANSPLANTATION AT THE UNIVERSITY-OF-MINNESOTA. KIDNEY INTERNATIONAL, S25-S30.

PRELIMINARY-RESULTS OF LOW-DOSE CYCLOSPORINE-A IN PEDIATRIC RENAL-TRANSPLANTATION
Nevins, T. E., Knaak, M., So, S. Ks., Chavers, B., Melvin, T., & Najarian, J. S. (1986). PRELIMINARY-RESULTS OF LOW-DOSE CYCLOSPORINE-A IN PEDIATRIC RENAL-TRANSPLANTATION. INTERNATIONAL JOURNAL OF PEDIATRIC NEPHROLOGY, 7(2), 91-94.

IMPROVED RESULTS OF MULTIPLE RENAL-TRANSPLANTATION IN CHILDREN
So, S. Ks., SIMMONS, R. L., FRYD, D. S., Najarian, J. S., & Mauer, S. M. (1985). IMPROVED RESULTS OF MULTIPLE RENAL-TRANSPLANTATION IN CHILDREN. SURGERY, 98(4), 729-737.

PRELIMINARY-RESULTS OF RENAL-TRANSPLANTATION IN CHILDREN UNDER 1 YEAR OF AGE
So, S. Ks., Nevins, T. E., Chang, P. N., Mauer, S. M., Ascher, N. L., & Najarian, J. S. (1985). PRELIMINARY-RESULTS OF RENAL-TRANSPLANTATION IN CHILDREN UNDER 1 YEAR OF AGE. TRANSPLANTATION PROCEEDINGS, 17(1), 182-183.

THE LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY ON RENAL-ALLOGRAFT SURVIVAL - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY
Sutherland, D. Er., FRYD, D. S., So, S. Ks., Strand, M., Ascher, N. L., & Najarian, J. S. (1985). THE LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY ON RENAL-ALLOGRAFT SURVIVAL - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY. TRANSPLANTATION PROCEEDINGS, 17(1), 136-137.

IMMUNOSPECIFIC LYMPHOCYTE-MEDIATED INJURY OF ISOLATED HEPATOCYTES
Harty, J. T., So, S. Ks., Keller, G. A., Hoffman, R., Ascher, N. L., & SIMMONS, R. L. (1985). IMMUNOSPECIFIC LYMPHOCYTE-MEDIATED INJURY OF ISOLATED HEPATOCYTES. TRANSPLANTATION PROCEEDINGS, 17(1), 606-607.

HEPATOCYTES ARE ALLOSPECIFIC TARGETS FOR CYTOLYTIC LYMPHOCYTE CLONES
So, S. Ks., Harty, J. T., Hoffman, R. A., Platt, J. L., BIEL, L. W., & SIMMONS, R. L. (1985). HEPATOCYTES ARE ALLOSPECIFIC TARGETS FOR CYTOLYTIC LYMPHOCYTE CLONES. SURGICAL FORUM, 36, 331-333.

THROMBOSED SYNTHETIC HEMODIALYSIS ACCESS FISTULAS - FAILURE OF FIBRINOLYTIC THERAPY
Young, A. T., Hunter, D. W., CASTANEDAZUNIGA, W. R., So, S. Ks., Mercado, S., & Amplatz, K. (1985). THROMBOSED SYNTHETIC HEMODIALYSIS ACCESS FISTULAS - FAILURE OF FIBRINOLYTIC THERAPY. RADIOLOGY, 154(3), 639-642.

HICKMAN CATHETER FOR PEDIATRIC HEMODIALYSIS - A 3-YEAR EXPERIENCE
So, S. Ks., Mahan, J. D., Mauer, S. M., Sutherland, D. Er., & Nevins, T. E. (1984). HICKMAN CATHETER FOR PEDIATRIC HEMODIALYSIS - A 3-YEAR EXPERIENCE. TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS, 30, 619-623.

LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY IN RENAL-TRANSPLANT PATIENTS - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY
Sutherland, D. Er., FRYD, D. S., So, S. Ks., Bentley, F. R., Ascher, N. L., & Najarian, J. S. (1984). LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY IN RENAL-TRANSPLANT PATIENTS - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY. TRANSPLANTATION, 38(6), 619-624.

FAILING OR THROMBOSED BRESCIA-CIMINO ARTERIOVENOUS DIALYSIS FISTULAS - ANGIOGRAPHIC EVALUATION AND PERCUTANEOUS TRANS-LUMINAL ANGIOPLASTY
Hunter, D. W., So, S. Ks., CASTANEDAZUNIGA, W. R., Coleman, C. E., Sutherland, D. Er., & Amplatz, K. (1983). FAILING OR THROMBOSED BRESCIA-CIMINO ARTERIOVENOUS DIALYSIS FISTULAS - ANGIOGRAPHIC EVALUATION AND PERCUTANEOUS TRANS-LUMINAL ANGIOPLASTY. RADIOLOGY, 149(1), 105-109.

BILE ASCITES DURING INFANCY - DIAGNOSIS USING DISOFENIN TC 99M SEQUENTIAL SCINTIPHOTOGRAPHY
So, S. Ks., Lindahl, J. A., Sharp, H. L., Cook, A. M., & Leonard, A. S. (1983). BILE ASCITES DURING INFANCY - DIAGNOSIS USING DISOFENIN TC 99M SEQUENTIAL SCINTIPHOTOGRAPHY. PEDIATRICS, 71(3), 402-405.

HBV markers in Chinese in Hong Kong.
Lam, K. C., Yuen, P., COLBOURNE, M. J., Chang, J., & So, S. (1980). HBV markers in Chinese in Hong Kong. Annals of the Academy of Medicine, Singapore, 9(2), 149-151.

COMBINED EFFECT OF RADIOTHERAPY AND NEURAMINIDASE-TREATED TUMOR-CELLS ON 3-METHYLCHOLANTHRENE-INDUCED FIBROSARCOMA
So, S. Ks., Song, C. W., Rios, A., & SIMMONS, R. L. (1977). COMBINED EFFECT OF RADIOTHERAPY AND NEURAMINIDASE-TREATED TUMOR-CELLS ON 3-METHYLCHOLANTHRENE-INDUCED FIBROSARCOMA. JOURNAL OF SURGICAL ONCOLOGY, 9(6), 527-540.